PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities
Journal of Thoracic Oncology · 2026-07 · 21 (7) · 104016
DOI: 10.1016/j.jtho.2026.104016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thoracic Oncology, 2026-07. Verfasst von Paul Stockhammer und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Stockhammer, P., Aidoo, E., Maemura, K., Kim, L. W., Kiyatkin, A., Grant, M., Goldberg, S. B., Lemmon, M. A., & Politi, K. (2026). PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities. Journal of Thoracic Oncology, 21(7), 104016. https://doi.org/10.1016/j.jtho.2026.104016
Vancouver
Stockhammer P, Aidoo E, Maemura K, Kim LW, Kiyatkin A, Grant M, et al. PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities. Journal of Thoracic Oncology. 2026;21(7):104016. doi:10.1016/j.jtho.2026.104016
BibTeX
@article{Stockhammer2026,
author = {Stockhammer, Paul and Aidoo, Erinda and Maemura, Keita and Kim, Lucy W. and Kiyatkin, Anatoly and Grant, Michael and Goldberg, Sarah B. and Lemmon, Mark A. and Politi, Katerina},
title = {PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities},
journal = {Journal of Thoracic Oncology},
year = {2026},
volume = {21},
number = {7},
pages = {104016},
doi = {10.1016/j.jtho.2026.104016}
}
EUVIMED